期刊文献+

我国不同地区自然人群甲肝平均感染力的定量研究 被引量:1

Quantitative Study on Average Infectious Hepatitis A in Natural Populations in Different Regions in China
下载PDF
导出
摘要 目的估计我国不同地区自然人群甲肝的平均感染力,为甲肝免疫策略定量研究提供基础参数。方法依据1992年全国病毒性肝炎血清流行病学调查资料,按各地调整的甲肝抗体流行率将全国划分为高度、中高度、中度、中低度和低度流行区。用简单催化模型对不同流行区的甲肝流行率资料进行拟合,估计甲肝的平均感染力。结果甲肝的平均感染力从高度到低度流行区分别为44.02%、23.09%、17.50%、10.24%和5.26%,拟合优度χ2检验后,P值均大于0.05。结论在自然人群中用简单催化模型拟合甲肝流行率资料,效果良好,获得的平均感染力数据可作为甲肝免疫策略定量研究中的基础参数。 Objective To estimate the average infectious power of hepatitis A in natural population in different regions of China, and provide basic parameters for the quantitative research of hepatitis A immunization strategies. Methods According to the data of the prevalence of hepatitis A antibodies in National Epidemiologieal survey of hepatitis in 1992, different regions were divided into a high, medium high, medium, medium low and low prevalence areas. Simple catalytic model was used to fit different prevalence rates of hepatitis A, and estimate the average infectious power of hepatitis A. Results The average infectious power of hepatitis A from high areas to low were: 44.02% , 23.09% , 17.50% , 10.24% and 5.26% respectively, The test of fitting goodness showed P values were greater than 0.05. Conclusion In natural populations of hepatitis A, using simple catalytic model fitting prevalence data can gain good effect. Data on average infectious power of hepatitis A provide basic parameters for the quantitative research of hepatitis A immunization strategies.
出处 《河南科技大学学报(医学版)》 2012年第1期71-73,共3页 Journal of Henan University of Science & Technology:Medical Science
基金 河南科技大学青年科学基金(2010QN0034)
关键词 甲肝 感染力 催化模型 hepatitis A infectious power catalytic model
  • 相关文献

参考文献1

二级参考文献8

共引文献93

同被引文献19

  • 1World Health Organization. WHO position paper on hepatitis A vaccines. Wkly Epidemiol Rec, 2000,75 : 38-44.
  • 2Holmberg SD. Hepatitis A epidemiology goes global. Clin Infect Dis, 2012,54(6) : 782-783.
  • 3Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR,2006,55(7) : 1-23.
  • 4Germinario C, Lopalco PL, Chirona M. From hepatitis B to hepatitis A and B prevention: The Puglia (Italy) experience. Vaccine, 2000,18 Suppl: S83-85.
  • 5卫生部信息统计中心.2011中国卫生统计年鉴.北京:中华人民共和国卫生部,2011.
  • 6王家良.循证医学:2版.北京:人民卫生出版社,2010:135.
  • 7Zhuang G, Pan X, Wang X. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. Vaccine, 2008,26: 4608-4616.
  • 8Jacobs R J, Greenberg DP, Koff RS, et al. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J, 2003,22 (10) : 904-914.
  • 9Valenzuela MT, Jacobs R J, Arteaga O, et al. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile. Vaccine, 2005,23:4110-4119.
  • 10Rein DB, Hicks KA, Wirth KE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics, 2007,119 ( 1 ) : e 12-21.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部